Global Anti-Infective Vaccines Market Research Report 2019

Table of Contents

Executive Summary

1 Anti-Infective Vaccines Market Overview

• 1.1 Product Overview and Scope of Anti-Infective Vaccines
• 1.2 Anti-Infective Vaccines Segment by Type
  • 1.2.1 Global Anti-Infective Vaccines Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Inactivated vaccines
  • 1.2.3 Conjugate vaccines
  • 1.2.4 Live/attenuated vaccines
• 1.3 Anti-Infective Vaccines Segment by Application
  • 1.3.1 Anti-Infective Vaccines Consumption Comparison by Application (2014-2025)
  • 1.3.2 Bacterial diseases
  • 1.3.3 Viral diseases
• 1.4 Global Anti-Infective Vaccines Market by Region
  • 1.4.1 Global Anti-Infective Vaccines Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Anti-Infective Vaccines Market Size
  • 1.5.1 Global Anti-Infective Vaccines Revenue (2014-2025)
  • 1.5.2 Global Anti-Infective Vaccines Production (2014-2025)

2 Global Anti-Infective Vaccines Market Competition by Manufacturers

• 2.1 Global Anti-Infective Vaccines Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Anti-Infective Vaccines Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Anti-Infective Vaccines Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Anti-Infective Vaccines Production Sites, Area Served, Product Types
• 2.5 Anti-Infective Vaccines Market Competitive Situation and Trends
  • 2.5.1 Anti-Infective Vaccines Market Concentration Rate
  • 2.5.2 Anti-Infective Vaccines Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Infective Vaccines Production Market Share by Regions

• 3.1 Global Anti-Infective Vaccines Production Market Share by Regions
• 3.2 Global Anti-Infective Vaccines Revenue Market Share by Regions (2014-2019)
• 3.3 Global Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Anti-Infective Vaccines Production
  • 3.4.1 North America Anti-Infective Vaccines Production Growth Rate (2014-2019)
  • 3.4.2 North America Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Anti-Infective Vaccines Production
  • 3.5.1 Europe Anti-Infective Vaccines Production Growth Rate (2014-2019)
  • 3.5.2 Europe Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Anti-Infective Vaccines Production (2014-2019)
  • 3.6.1 China Anti-Infective Vaccines Production Growth Rate (2014-2019)
  • 3.6.2 China Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Anti-Infective Vaccines Production (2014-2019)
  • 3.7.1 Japan Anti-Infective Vaccines Production Growth Rate (2014-2019)
  • 3.7.2 Japan Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Anti-Infective Vaccines Consumption by Regions

• 4.1 Global Anti-Infective Vaccines Consumption by Regions
• 4.2 North America Anti-Infective Vaccines Consumption (2014-2019)
• 4.3 Europe Anti-Infective Vaccines Consumption (2014-2019)
• 4.4 China Anti-Infective Vaccines Consumption (2014-2019)
• 4.5 Japan Anti-Infective Vaccines Consumption (2014-2019)

5 Global Anti-Infective Vaccines Production, Revenue, Price Trend by Type

• 5.1 Global Anti-Infective Vaccines Production Market Share by Type (2014-2019)
• 5.2 Global Anti-Infective Vaccines Revenue Market Share by Type (2014-2019)
• 5.3 Global Anti-Infective Vaccines Price by Type (2014-2019)
• 5.4 Global Anti-Infective Vaccines Production Growth by Type (2014-2019)

6 Global Anti-Infective Vaccines Market Analysis by Applications

• 6.1 Global Anti-Infective Vaccines Consumption Market Share by Application (2014-2019)
• 6.2 Global Anti-Infective Vaccines Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Anti-Infective Vaccines Business

• 7.1 Emergent BioDefense Operations Lansing Inc.
  • 7.1.1 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Production Sites and Area Served
  • 7.1.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Sanofi Pasteur
  • 7.2.1 Sanofi Pasteur Anti-Infective Vaccines Production Sites and Area Served
  • 7.2.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.2.3 Sanofi Pasteur Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Merck & Co.
  • 7.3.1 Merck & Co. Anti-Infective Vaccines Production Sites and Area Served
  • 7.3.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.3.3 Merck & Co. Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 MedImmune LLC
  • 7.4.1 MedImmune LLC Anti-Infective Vaccines Production Sites and Area Served
  • 7.4.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.4.3 MedImmune LLC Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Novartis Vaccines
  • 7.5.1 Novartis Vaccines Anti-Infective Vaccines Production Sites and Area Served
  • 7.5.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.5.3 Novartis Vaccines Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Diagnostics Ltd.
  • 7.6.1 Diagnostics Ltd. Anti-Infective Vaccines Production Sites and Area Served
  • 7.6.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.6.3 Diagnostics Ltd. Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Intercell Biomedical
  • 7.7.1 Intercell Biomedical Anti-Infective Vaccines Production Sites and Area Served
  • 7.7.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.7.3 Intercell Biomedical Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 MassBiologics
  • 7.8.1 MassBiologics Anti-Infective Vaccines Production Sites and Area Served
  • 7.8.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.8.3 MassBiologics Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Barr Labs, Inc.
  • 7.9.1 Barr Labs, Inc. Anti-Infective Vaccines Production Sites and Area Served
  • 7.9.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.9.3 Barr Labs, Inc. Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Organon Teknika Co.
  • 7.10.1 Organon Teknika Co. Anti-Infective Vaccines Production Sites and Area Served
  • 7.10.2 Anti-Infective Vaccines Product Introduction, Application and Specification
  • 7.10.3 Organon Teknika Co. Anti-Infective Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 GlaxoSmithKline Biologicals
• 7.12 CSL Ltd.
• 7.13 ID Biomedical Co.
• 7.14 Protein Sciences Co.
• 7.15 Wyeth Pharmaceuticals, Inc.
• 7.16 Berna Biotech

8 Anti-Infective Vaccines Manufacturing Cost Analysis

• 8.1 Anti-Infective Vaccines Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Anti-Infective Vaccines
• 8.4 Anti-Infective Vaccines Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Anti-Infective Vaccines Distributors List
• 9.3 Anti-Infective Vaccines Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Anti-Infective Vaccines Market Forecast

• 11.1 Global Anti-Infective Vaccines Production, Revenue Forecast
  • 11.1.1 Global Anti-Infective Vaccines Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Anti-Infective Vaccines Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Anti-Infective Vaccines Price and Trend Forecast (2019-2025)
• 11.2 Global Anti-Infective Vaccines Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Anti-Infective Vaccines Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Anti-Infective Vaccines Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Anti-Infective Vaccines Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Anti-Infective Vaccines Production, Revenue Forecast (2019-2025)
• 11.3 Global Anti-Infective Vaccines Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Anti-Infective Vaccines Consumption Forecast (2019-2025)
  • 11.3.2 Europe Anti-Infective Vaccines Consumption Forecast (2019-2025)
  • 11.3.3 China Anti-Infective Vaccines Consumption Forecast (2019-2025)
  • 11.3.4 Japan Anti-Infective Vaccines Consumption Forecast (2019-2025)
• 11.4 Global Anti-Infective Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Anti-Infective Vaccines Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List